Keyphrases
Anticonvulsive
5%
Antiseizure Medication
50%
Anxiety Symptoms
50%
Anxiety-depression
7%
Ataxia
5%
Barbital
20%
Clinical Effect
5%
Clonazepam
15%
Comparative Analysis
50%
Days of Treatment
5%
Depressive Symptoms
50%
Disability Paradox
7%
Drosophila Model
50%
Ethosuximide
10%
GABAA
50%
GABAA Receptor (GABAAR)
5%
Ganaxolone
20%
GOSR2
5%
Groningen
7%
Heat Sensitivity
5%
Heat-induced
5%
High Dose
5%
Homozygous mutation
5%
Hyperkinetic Movement Disorders
50%
Levetiracetam
10%
Mode of Action
5%
Movement Disorders
11%
Myoclonus
10%
Myoclonus Epilepsy
50%
North Sea Progressive Myoclonus Epilepsy
50%
Progressive Course
5%
Progressive Myoclonus Epilepsy
5%
Quality of Life
50%
Quality of Life Assessment
7%
Rare Genetic Disease
5%
Seizure
25%
Seizure Suppression
20%
Sodium
20%
Third Generation
5%
University Medical Centre
7%
Valproic Acid
10%
Neuroscience
Anti-Seizure Medication
50%
Antiseizure Medication
50%
Ataxia
7%
Barbital
15%
Clonazepam
11%
Depressive Disorder
50%
Ethosuximide
7%
Ganaxolone
15%
Levetiracetam
7%
Myoclonus
100%
Stereotypic Movement Disorder
50%
Valproic Acid
7%
Medicine and Dentistry
Barbital
12%
Depressive Disorder
50%
Lafora Disease
50%
Quality of Life
50%
Short Form 36
7%
Stereotypic Movement Disorder
50%
